Jesus G Berdeja

6 days ago | tandfonline.com | Sagar Lonial |Meletios A. Dimopoulos |Jesus G Berdeja |Paul Richardson

ABSTRACTMultiple myeloma (MM) is a plasma cell neoplasm that stems from the malignant transformation of clonal plasma cells. It is characterized by multiple periods of remission and relapse requiring multiple lines of therapy, with response to treatment and survival decreasing with each successive relapse. To achieve deep and durable responses in relapsed/refractory MM (RRMM), novel treatments are required.